Adc Therapeutics SA Overview

Adc Therapeutics SA Other Income Expense Net

Other Income/Expense Net for ADCT.

Quarterly Other Income/Expense

-$7.72M

↑ 22.56% YoY

As of Mar 31, 2026

Annual Other Income/Expense (TTM)

-$32.15M

↓ 36.05% YoY

Trailing 12 months ending Mar 31, 2026

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin